“…The fraction (138 mg) of column B eluted with 60 ± 65 % MeOH (the 1100 ± 2000 mL fraction) was then separated on Sephadex LH-20 (13 500 mm) eluted with MeOH, followed by purification with HPLC (Develosil ODS UG-5, 10 250 mm, eluent, 80 % MeOH; flow rate, 1.5 mL/ min) to afford austroinulin (1, 4.6 mg) in the 75 ± 85 mL fraction. The fraction (182 mg) of column B eluted with 50 % MeOH (the 75 ± 85 mL fraction) was further separated on Sephadex LH-20 (column C: 13 500 mm) eluted with MeOH to give cryptomeridiol (11) [3] (25.5 mg) in the 80 ± 90 mL fraction, and the fraction of column C eluted with 120 ± 130 mL was purified by HPLC (Develosil ODS UG-5, 10 250 mm, eluent, 80 % MeOH; flow rate, 1. : + 16.98 (c 1.35, MeOH)} in the 0 ± 40 mL fraction. The fraction (185 mg) of column D eluted with 50 ± 100 % EtOAc in hexane (the 1100 ± 1400 mL fraction) was subjected to separation by an ODS sep-pak cartridge (70 % MeOH), followed by purification of the 0 ± 40 mL fraction with HPLC (Develosil ODS UG-5, 10 250 mm, eluent, 65 % MeOH; flow rate, 1.5 mL/min) to yield 4¢-hydroxy-5,6,7,3¢,5¢-pentamethoxyflavone (5, t R 19 min) [6] (2.8 mg), 5,6,7,3¢,4¢,5¢-hexamethoxyflavone (6, t R 27 min) [7] (14.1 mg), nobiletin (7, t R 36 min) [8] (10.6 mg), 5¢-methoxynobiletin (8, t R 42 min) [8] (35.4 mg), and 5,6,7,8,5¢-pentamethoxy-3¢,4¢-methylenedioxyflavone (9, t R 54 min) [8] (5.3 mg), while the fraction (26 mg) of column D eluted with 25 % EtOAc in hexane (the 300 ± 500 mL fraction) was also subjected to separation by an ODS sep-pak cartridge (70 % MeOH), followed by purification of the 0 ± 40 mL fraction with HPLC (Develosil ODS UG-5, 10 250 mm, eluent, 65 % MeOH; flow rate, 1.5 mL/min) to give sakuranetin {10, t R 41 min; [a] D 25 : ±23.28 (c 1.20, MeOH)) [4], [9] (1.9 mg).…”